Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Capital Expenditures: 2020-2025

Historic Capital Expenditures for Benitec Biopharma (BNTC) over the last 1 years, with Mar 2025 value amounting to $6,000.

  • Benitec Biopharma's Capital Expenditures was N/A to $6,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$121,000, marking a year-over-year change of. This contributed to the annual value of $18,000 for FY2025, which is 89.94% down from last year.
  • Per Benitec Biopharma's latest filing, its Capital Expenditures stood at $6,000 for Q1 2025, which was up 500.00% from $1,000 recorded in Q2 2023.
  • In the past 5 years, Benitec Biopharma's Capital Expenditures ranged from a high of $15,000 in Q1 2021 and a low of -$141,000 during Q2 2021.
  • For the 2-year period, Benitec Biopharma's Capital Expenditures averaged around $3,500, with its median value being $3,500 (2023).
  • As far as peak fluctuations go, Benitec Biopharma's Capital Expenditures slumped by 1,184.62% in 2021, and later soared by 109.22% in 2022.
  • Quarterly analysis of 4 years shows Benitec Biopharma's Capital Expenditures stood at -$141,000 in 2021, then skyrocketed by 109.22% to $13,000 in 2022, then tumbled by 92.31% to $1,000 in 2023, then reached $6,000 in 2025.
  • Its last three reported values are $6,000 in Q1 2025, $1,000 for Q2 2023, and $13,000 during Q2 2022.